Metropolitan Life Insurance Company (MetLife)’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,319
Closed -$566K 2548
2017
Q3
$566K Sell
19,319
-3,408
-15% -$95.5K ﹤0.01% 1602
2017
Q2
$597K Hold
22,727
﹤0.01% 1556
2017
Q1
$532K Sell
22,727
-1,156
-5% -$28.5K ﹤0.01% 1606
2016
Q4
$601K Hold
23,883
﹤0.01% 1616
2016
Q3
$670K Hold
23,883
﹤0.01% 1522
2016
Q2
$589K Hold
23,883
﹤0.01% 1586
2016
Q1
$528K Buy
23,883
+2,665
+13% +$70.9K ﹤0.01% 1555
2015
Q4
$743K Hold
21,218
0.01% 1359
2015
Q3
$604K Hold
21,218
﹤0.01% 1511
2015
Q2
$707K Sell
21,218
-807
-4% -$24.8K 0.01% 1518
2015
Q1
$621K Sell
22,025
-356
-2% -$8.85K ﹤0.01% 1442
2014
Q4
$464K Hold
22,381
﹤0.01% 1809
2014
Q3
$547K Sell
22,381
-3,303
-13% -$87.6K ﹤0.01% 1663
2014
Q2
$734K Hold
25,684
0.01% 1558
2014
Q1
$719K Hold
25,684
0.01% 1568
2013
Q4
$552K Hold
25,684
﹤0.01% 1743
2013
Q3
$341K Hold
25,684
﹤0.01% 2009
2013
Q2
$356K Buy
+25,684
New +$364K ﹤0.01% 1932

Metropolitan Life Insurance Company (MetLife)'s PMC Position: Q4 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 19,319 shares — an estimated $566K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $743K in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 19,319 PharMerica Corporation shares in Q4 2017, an estimated $566K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s PharMerica Corporation position peaked at $743K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.